Literature DB >> 6999173

Histologic grading of primary prostatic cancer: a new approach to an old problem.

J F Gaeta, J E Asirwatham, G Miller, G P Murphy.   

Abstract

A simple and objective system for grading prostatic carcinoma was evaluated in a retrospective analysis of 169 cases followed during a 16-year period. The system identified and separated 4 grades of increasing malignancy based on the combined evaluation of gland differentiation and nuclear anaplasia as separate but complementary factors. The system demonstrates significant correlation with mortality rates for each grade group. Retrospective evaluation of the extent of the disease at the time of initial diagnosis also indicates correlation between prostatic grades and clinical stages.

Entities:  

Mesh:

Year:  1980        PMID: 6999173     DOI: 10.1016/s0022-5347(17)56093-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  Clinical implications of changing definitions within the Gleason grading system.

Authors:  Tamara L Lotan; Jonathan I Epstein
Journal:  Nat Rev Urol       Date:  2010-02-16       Impact factor: 14.432

2.  Nuclear grading versus Gleason grading in small samples containing prostate cancer: a tissue microarray study.

Authors:  Daniel Wittschieber; Jens Köllermann; Thorsten Schlomm; Guido Sauter; Andreas Erbersdobler
Journal:  Pathol Oncol Res       Date:  2010-04-23       Impact factor: 3.201

3.  Analysis of Gleason grade and scores in 90 Nigerian Africans with prostate cancer during the period 1994 to 2004.

Authors:  U G Ugare; I E Bassey; P G Jibrin; I A Ekanem
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

4.  Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma.

Authors:  N Konishi; Y Hiasa; H Matsuda; M Tao; T Tsuzuki; I Hayashi; Y Kitahori; T Shiraishi; R Yatani; J Shimazaki
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

5.  Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate.

Authors:  G Dhom
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

6.  Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA.

Authors:  P J Hepburn; E Glynne-Jones; L Goddard; J M Gee; M E Harper
Journal:  Histochem J       Date:  1995-03

Review 7.  Screening for carcinoma of the prostate: efficacy of available screening tests.

Authors:  I M Thompson; W R Fair
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

8.  Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.

Authors:  S Vesalainen; S Nordling; P Lipponen; M Talja; K Syrjänen
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.